LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio SME BioForum: a new voice for the biotechnology SME community in Europe

27/04/2022
PRESS RELEASE
Brussels, 28 April 2022

EuropaBio – the European Association for Bioindustries is pleased to present the SME BioForum, a new activity in 2022 within the framework of its SME Platform.

EuropaBio's SME Platform represents the biotechnology SME community in Europe, in close partnership with EuropaBio's National Associations Council, and advocates for innovative biotechnology delivered through SMEs.

The 2022 SME BioForum will organise two discussion-driven meetings for SME executives in May and October. They will bring together SMEs across countries, market applications, technology platforms and stages of growth, creating an exceptional opportunity to discuss biotechnology commercial development challenges and how the European landscape impacts their ability to grow and deliver to market.

‘We are delighted to offer an exclusive platform for SMEs which provides an environment to address policy framework in which European companies scale up and return on investment here in Europe. It is driven by SMEs and EuropaBio will ensure that their voices are heard at the highest level in policy development so that Europe reaps the benefit from the excellence of its science and innovation.”, said Dr Claire Skentelbery, Director General of EuropaBio.

The meetings will be invitation-only for SME members of EuropaBio and its National Associations plus SME participants at the EFIB conference.

The first 90 minute event will be held online on May 31, 2022. It will focus on Healthcare Biotechnology with the main theme on Advanced Therapy Medicinal Products (ATMPs). The second session, in October, will focus on Industrial Biotechnology, and it will take place in person in Vilnius, Lithuania, during the 2022 European Forum for Industrial Biotechnology and the Bioeconomy (EFIB).

For more information about opportunities of participation please contact José Peres, NAC & SME Coordinator.

EuropaBio SME BioForum: a new voice for the biotechnology SME community in Europe


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
21/05/2025

Ensuring Biotech Integration in the Single Market


Read more
10/04/2025

EU biotechnology competitiveness for the future; high level dialogue with EVP Séjourné


Read more

Important links

  • Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World
  • Ensuring Biotech Integration in the Single Market

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.